Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
- Written by PR Newswire Asia - Daily Bulletin Au RSS
![]() |
Highlights:
- Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement
- Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and outlines key terms for a future...